Younes
Smani
Publicaciones (88) Publicaciones de Younes Smani
2024
-
Antibiotic discovery with artificial intelligence for the treatment of Acinetobacter baumannii infections
mSystems, Vol. 9, Núm. 6
-
Discovery of new antimicrobial thiophene derivatives with activity against drug-resistant Gram negative-bacteria
Frontiers in Pharmacology, Vol. 15
-
Efficacy of Tamoxifen Metabolites in Combination with Colistin and Tigecycline in Experimental Murine Models of Escherichia coli and Acinetobacter baumannii
Antibiotics, Vol. 13, Núm. 5
-
Solving the antibacterial resistance in Europe: The multipronged approach of the COST Action CA21145 EURESTOP
Drug Resistance Updates
2023
-
Anthelmintic Drugs for Repurposing against Gram-Negative Bacilli Infections
Current Medicinal Chemistry, Vol. 30, Núm. 1, pp. 59-71
-
Estudio de interacción patógeno-huésped para el descubrimiento de nuevo sagentes antibacterianos
Investigaciones DACIU 2022-2023: Una publicación que refleja los trabajos realizados por los participantes en el programa DACIU en su primera edición (Avanza), pp. 42-47
-
In Vitro and In Vivo Virulence Study of Listeria monocytogenes Isolated from the Andalusian Outbreak in 2019
Tropical Medicine and Infectious Disease, Vol. 8, Núm. 1
-
In vitro and in vivo evaluation of two combined β-lactamase inhibitors against carbapenem-resistant Acinetobacter baumannii
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 42, Núm. 11, pp. 1317-1325
-
Role of blaTEM and OmpC in the piperacillin-tazobactam resistance evolution by E. coli in patients with complicated intra-abdominal infection
Journal of Infection, Vol. 87, Núm. 3, pp. 220-229
2022
-
Corrigendum: Drug Repurposing for the Treatment of Bacterial and Fungal Infections (Front. Microbiol., (2019), 10, (41), 10.3389/fmicb.2019.00041)
Frontiers in Microbiology
-
Editorial: Drug re-purposing for the treatment of bacterial infections
Frontiers in Pharmacology
-
Impact of the immune response modification by lysophosphatidylcholine in the efficacy of antibiotic therapy of experimental models of peritoneal sepsis and pneumonia by Pseudomonas aeruginosa: LPC therapeutic effect in combined therapy
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 1, pp. 14-21
-
Repurposing of the tamoxifen metabolites in combination with tigecycline against Gram-negative bacteria.
Biosaia: Revista de los másteres de Biotecnología Sanitaria y Biotecnología Ambiental, Industrial y Alimentaria, Núm. 11
-
Tissue engineered in-vitro vascular patch fabrication using hybrid 3D printing and electrospinning
Materials Today Bio, Vol. 14, pp. 100252
-
Ultrasensitive and rapid identification of ESRI developer- and piperacillin/tazobactam-resistant Escherichia coli by the MALDIpiptaz test
Emerging Microbes and Infections, Vol. 11, Núm. 1, pp. 2034-2044
-
iTRAQ-Based Quantitative Proteomic Analysis of Acinetobacter baumannii under Hypoxia and Normoxia Reveals the Role of OmpW as a Virulence Factor
Microbiology Spectrum, Vol. 10, Núm. 2, pp. 11 p.
2021
-
AOA-2 Derivatives as Outer Membrane Protein A Inhibitors for Treatment of Gram-Negative Bacilli Infections
Frontiers in Microbiology, Vol. 12
-
Editorial: Antivirulence Drugs Against Bacterial Infections
Frontiers in Microbiology
-
Efficacy of lysophosphatidylcholine as direct treatment in combination with colistin against acinetobacter baumannii in murine severe infections models
Antibiotics, Vol. 10, Núm. 2, pp. 1-8
-
Impact of the COVID-19 Pandemic on Survival in the Patients With the Intra-Abdominal Infections
Frontiers in Medicine, Vol. 8